Literature DB >> 25634747

Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis.

Anja C Roden1, Eunhee S Yi, Sarah M Jenkins, Kelly K Edwards, Janis L Donovan, Jean E Lewis, Stephen D Cassivi, Randolph S Marks, Yolanda I Garces, Marie Christine Aubry.   

Abstract

Data regarding the prognostic significance of the histopathologic classifications of thymic epithelial neoplasms are contradictory, perhaps reflecting issues in reproducibility. We studied the effect of reproducibility of 3 histopathologic classifications on prognosis and investigated the interobserver agreement on invasion and its effect on staging and prognosis. A total of 456 patients who underwent surgery for thymic epithelial neoplasm at Mayo Clinic Rochester (1942 to 2008) were staged (modified Masaoka, proposed Moran, proposed IASLC/ITMIG) and independently classified by 3 thoracic pathologists (World Health Organization, proposed Suster & Moran [S&M], and Bernatz). Interobserver agreement was moderate to substantial for all histopathologic classifications (κ values: 0.65, 0.52, 0.74 for World Health Organization, Bernatz, and S&M, respectively). All histopathologic classifications were significant for overall survival (OS) and disease-free survival (DFS) (all reviewers). If adjusted for Masaoka, only Bernatz classification for one reviewer and all histopathologic classifications for another reviewer were significant for OS. Interobserver agreement for invasion was substantial (κ=0.61) and almost perfect for Masaoka, Moran, and IASLC/ITMIG stage (κ values: 0.85, 0.81, and 0.92, respectively). The correlation coefficient for Masaoka and Moran staging was 0.93. Masaoka and IASLC/ITMIG staging were significant for OS and DFS (all reviewers). If adjusted for any histopathologic classification, Masaoka was significant for OS and DFS (all reviewers). In conclusion, reproducibility of histopathologic classifications has some effect on outcome. S&M is the most reproducible classification. Reproducibility of invasion has no effect on the prognostic value of staging. Masaoka, Moran, and IASLC/ITMIG staging are almost perfectly reproducible. The strong correlation between Masaoka and Moran staging suggests similar prognostic strength.

Entities:  

Mesh:

Year:  2015        PMID: 25634747     DOI: 10.1097/PAS.0000000000000391

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  CD117, BAP1, MTAP, and TdT Is a Useful Immunohistochemical Panel to Distinguish Thymoma from Thymic Carcinoma.

Authors:  Mounika Angirekula; Sindy Y Chang; Sarah M Jenkins; Patricia T Greipp; William R Sukov; Randolph S Marks; Kenneth R Olivier; Stephen D Cassivi; Anja C Roden
Journal:  Cancers (Basel)       Date:  2022-05-05       Impact factor: 6.575

2.  Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors.

Authors:  Sukhmani K Padda; Donato Terrone; Lu Tian; Amanda Khuong; Joel W Neal; Jonathan W Riess; Mark F Berry; Chuong D Hoang; Bryan M Burt; Ann N Leung; Erich J Schwartz; Joseph B Shrager; Heather A Wakelee
Journal:  J Thorac Imaging       Date:  2018-05       Impact factor: 3.000

3.  Pathological discrepancies in the diagnosis of thymic epithelial tumors: the Tallinn-Lyon experience.

Authors:  Kersti Oselin; Nicolas Girard; Katrin Lepik; Aidi Adamson-Raieste; Tõnu Vanakesa; Ingemar Almre; Tiina Leismann; Lara Chalabreysse
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

4.  Incidence and clinical variable inter-relationships of thymic epithelial tumors in northwest China.

Authors:  Xiu-Long Feng; Xue-Bin Lei; Wen-Ting Dong; Lin-Feng Yan; Yong-Kang Xin; Gang-Feng Li; Yong Jing; Shi-Jun Duan; Jie Zhang; Yu-Chuan Hu; Bo Li; Sha-Sha Zhao; Qian Sun; Jin Zhang; Tao Zhang; Dong-Liang Cheng; Guang-Bin Cui; Wen Wang
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

5.  CT imaging-based machine learning model: a potential modality for predicting low-risk and high-risk groups of thymoma: "Impact of surgical modality choice".

Authors:  Ayten Kayi Cangir; Kaan Orhan; Yusuf Kahya; Hilal Özakıncı; Betül Bahar Kazak; Buse Mine Konuk Balcı; Duru Karasoy; Çağlar Uzun
Journal:  World J Surg Oncol       Date:  2021-05-11       Impact factor: 2.754

6.  Epidemiology of thymic epithelial tumors: 22-years experience from a single-institution.

Authors:  Patricia Rioja; Rossana Ruiz; Marco Galvez-Nino; Sophia Lozano; Natalia Valdiviezo; Mivael Olivera; Octavio Cabero; Maria Eugenia Guillen; Alberto De La Guerra; Edgar Amorin; Carlos Barrionuevo; Luis Mas
Journal:  Thorac Cancer       Date:  2020-12-23       Impact factor: 3.500

7.  Interobserver variation in the classification of thymic lesions including biopsies and resection specimens in an international digital microscopy panel.

Authors:  Janina L Wolf; Francien van Nederveen; Hans Blaauwgeers; Alexander Marx; Andrew G Nicholson; Anja C Roden; Philipp Ströbel; Wim Timens; Annika Weissferdt; Jan von der Thüsen; Michael A den Bakker
Journal:  Histopathology       Date:  2020-09-24       Impact factor: 5.087

8.  A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA.

Authors:  Margaret Ottaviano; Mario Giuliano; Marianna Tortora; Evelina La Civita; Antonietta Liotti; Michele Longo; Dario Bruzzese; Michele Cennamo; Vittorio Riccio; Pietro De Placido; Fernanda Picozzi; Sara Parola; Bruno Daniele; Gerardo Botti; Pietro Formisano; Francesco Beguinot; Sabino De Placido; Daniela Terracciano; Giovannella Palmieri
Journal:  Front Oncol       Date:  2021-02-04       Impact factor: 6.244

9.  Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas.

Authors:  David Suster; James A Miller; German Pihan; A Craig Mackinnon; Saul Suster
Journal:  Mod Pathol       Date:  2021-06-16       Impact factor: 7.842

10.  Deciphering tissue-based proteome signatures revealed novel subtyping and prognostic markers for thymic epithelial tumors.

Authors:  Xin Ku; Qiangling Sun; Lei Zhu; Zhitao Gu; Yuchen Han; Ning Xu; Chen Meng; Xiaohua Yang; Wei Yan; Wentao Fang
Journal:  Mol Oncol       Date:  2020-02-06       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.